IOVA · Mid Cap · Healthcare · Biotechnology
Free AI brief
Free to track. No card required. Usually ready in 10-15 minutes.
Price, momentum, and the numbers behind the story.
Stocksbrew score
64/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Lowest
$7
Median target
$13.5
Current price
$14.55
Highest
$20
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Debt / equity
Favorable · 0.06 - strong leverage
0.06x
Current ratio
Strong · Good liquidity position
4.35x
Price / sales
Rich · Overpriced by revenue
20.38x
ROIC
Weak · Weak capital efficiency
-24.1%
ROE
Needs attention · Unfavorable
-40.4%
IOVA against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $6.62B | - | +34.5% | 64 | |
| $10.02B | 19.1 | +19.7% | 78 | |
| $31.74B | 33.2 | +15.5% | 78 | |
| $4.23B | 12.7 | +13.5% | 78 | |
| $1.11T | 40.1 | +49.6% | 77 |
Every story that touched the stock this week, newest first.